This approval, however, leaves Vorasidenib inaccessible to patients in the rest of the UK and Ireland. We support Brain Cancer Justice in their call to the NHS and NICE to introduce vorasidenib into the clinic UK-wide.
Some further positive news is yesterday’s approval of vorasidenib (Voranigo) by The Scottish Medicines Consortium for use in treating certain populations with IDH-mutated low grade gliomas (read more: www.thebraintumourcharity.org/news/researc...).
This petition is a call for the UK government to provide transparent use of funding, as well as investigational drug Right To Try protections for terminally ill patients.
March is Brain Tumour Awareness Month🎗️🧠 Yesterday, our team stood with Brain Cancer Justice at Parliament Square, to commemorate their petition reaching 100,000 signatures and being delivered to parliament for debate consideration.
#BrainCancerAwarenessMonth #BrainCancerResearch #GBM
At CoSyne, our mission is driven by incredible women scientists. 👩🔬💻 On this International Day of Women and Girls in Science, we’re proud to celebrate the innovators on our team.
#WomenInScience #IDWGS2026 #Biotech #BrainCancerResearch #STEM #WomenInSTEM
At CoSyne, we focus on speeding up the translation of treatments from the lab to the clinic, because we know time is the most valuable asset a patient has. We’re proud to be part of the UK’s life sciences community, working toward a day where "1 in 2" is a statistic of the past.
Today is #WorldCancerDay. In our lifetimes, 1 in 2 of us will face a cancer diagnosis. While 10-year survival rates have reached 50%, progress remains uneven for less survivable cancers like glioblastoma.
#UnitedByUnique #BrainCancer #GBM #DrugDiscovery #BrainCancerResearch
The conference provided many opportunities to seed new partnerships and establish pathways to translate our science into impact for rare disease patients in 2026. We also welcomed the chance to reconnect with the advisors, investors, and supporters who are integral to our mission.
The CoSyne team had a fantastic time at the JP Morgan Healthcare conference in San Francisco last week!
#JPM2026 #CoSyneTherapeutics #BioTech #RareDisease #GBM
The CoSyne team got together at our Christmas party last week, for an afternoon filled with delicious food, thoughtful Secret Santa gifts, and finding out who had some hidden curling talents! 🎅🎁🥌
🎄✨ Merry Christmas & happy holidays from our team to yours!
A huge thank you to the entire team and collaborators whose work made this possible! [5/5]
Our findings suggest that cytarabine could provide a targeted treatment option for a genetically defined group of patients with leptomeningeal dissemination of glioma, making an existing therapy newly actionable through biomarker guidance. [4/5]
This work highlighted a strong dependency on DNA polymerase pathways and pointed us toward cytarabine, an existing FDA-approved drug. When we tested cytarabine across several glioma models, we found that tumours with both TP53 and RB1 intact were significantly more sensitive than others. [3/5]
In this study, we used large-scale CRISPRi screening in patient-derived glioma models to identify the genetic weaknesses of these tumours. [2/5]
📣 Excited to share our latest pre-print in precision medicine and molecular drug response stratification in brain tumours. [1/5] www.biorxiv.org/content/10.1...
#glioblastoma #GBM #biomarkerdiscovery #patientstratification #drugrepurposing
This week, the CoSyne team are heading to the beautiful Honolulu to join the SNO meeting! 🌺🌴
Come and find us to hear about CoSyne’s latest exciting glioblastoma biomarker findings… more on that later in the week!
#SNO2025 #glioblastoma #GBM #braincancer #neurooncology #drugdiscovery #biomarkers
🧠 At CoSyne, we are proud to be supporting the International Brain Tumour Alliance (IBTA) during this year’s International Brain Tumour Awareness Week!
For more information, visit the IBTA's website here: www.theibta.org
#IBTAWeek #braintumourawareness #glioblastoma
Winner winner chili dinner! 🌶️ 🏆 It turns out that brain cells aren’t the only thing we’re good at seeding…
Congrats to the experimental bio team in Cambridge who have taken out the JCBC chilli growing contest for most chilis on a single plant!
Great to have everyone together for our company offsite yesterday! It’s always great to connect as a full team, celebrate our wins, and align on the next phase of our journey 🙌🧠🚀
#CoSyneTherapeutics #Glioblastoma #Bioinformatics #DrugDiscovery #BrainCancerResearch
We’ve got an incredible interdisciplinary team here at CoSyne Therapeutics! Mi is a senior computational biologist analysing our genomic data generated in the wet lab, and Sophie is our operations coordinator who supports the senior leadership team and wider company 🖥️🧬📋🧠
MYTH vs FACT: Think you know the truth about brain cancer? Let’s break down some common misconceptions! 🧠
Have you heard this myth before? 💭⁉️
#Glioblastoma #GBM #BrainCancer #BrainCancerResearch #BioTech
A huge congratulations to our bioinformatician Grant who conquered the great Steall Marathon in the Scottish Highlands on the weekend! He finished with an impressive time of 7:03 and placed 85 of 231 finishers. 🏃 🏔️ 🎖️
#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #Fundraising
🔔 Don't miss a thing! Our journey to fight rare neurological disease is happening on all our social media channels, and we'd love for you to join us.
➕ Follow us on all our pages to get the full story and support our mission.
#Glioblastoma #DrugDiscovery #BrainCancerResearch
If you are a UK citizen or resident, please lend your voice to this cause! [3/3]
Their mission is our mission: to accelerate progress in brain cancer treatment. They're calling on the UK government to increase research funding, standardise genomic sequencing for better-informed treatment, and enact "Right to Try" laws for those with terminal diagnoses. [2/3]
We’re standing with Brain Cancer Justice, a new group founded by patients and advocates fighting for change. [1/3]
petition.parliament.uk/petitions/73...
#CoSyneTherapeutics #BrainCancerJustice #BrainCancer #Petition
#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #BioTech #KnowledgeGraphs
Instead of just relying on the data within the LLM compressed in its weights, the prompt contains now additional information from structured resources. Naturally, this can be also leveraged in agentic workflows that chain different tasks executed by the LLM together. [13/13]
🤖 Generative AI enhancement: Knowledge Graphs can provide structured data to large language models (LLM; for example ChatGPT) to reduce hallucinations and improve accuracy (known as retrieval augmented generation). [12/13]
📚 Biomedical literature: Which research groups are making similar discoveries? How strong is the evidence for a particular claim made in a research publication? Do we observe validation of findings/claims by other scientists? [11/13]
